[Effect of ursodeoxycholic acid treatment on primary biliary cirrhosis].
Raedsch
R
R
Stiehl
A
A
Hopf
U
U
Möller
B
B
D001647:Bile Acids and Salts / Q000097:blood; D001663:Bilirubin / Q000097:blood; D002780:Cholestasis, Intrahepatic / Q000188:drug therapy; D003840:Deoxycholic Acid / Q000031:analogs & derivatives*; D005500:Follow-Up Studies; D006801:Humans; D008105:Liver Cirrhosis, Biliary / Q000188:drug therapy*; D008111:Liver Function Tests; D010446:Peptide Fragments / Q000097:blood; D011347:Procollagen / Q000097:blood; D014580:Ursodeoxycholic Acid / Q000627:therapeutic use*
D001647:Bile Acids and Salts; D010446:Peptide Fragments; D011347:Procollagen; C041876:procollagen Type III-N-terminal peptide; D003840:Deoxycholic Acid; D014580:Ursodeoxycholic Acid; D001663:Bilirubin
Einfluss der Ursodesoxycholsäure-Behandlung auf die primär biliäre Zirrhose.